H
EDIT icon

HoyleCohen’s Editas Medicine EDIT Stock Holding History

HoyleCohen’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$55.3K Buy
+11,834
New +$66.8K ﹤0.01% 271
2022
Q1 		– Sell
-9,634
Closed -$256K – 277
2021
Q4 		$256K Buy
9,634
+350
+4% +$12K 0.02% 251
2021
Q3 		$381K Hold
9,284
– – 0.04% 203
2021
Q2 		$526 Buy
9,284
+200
+2% +$7.39K 0.04% 181
2021
Q1 		$382K Hold
9,084
– – 0.04% 198
2020
Q4 		$637K Buy
+9,084
New +$373K 0.07% 144
2020
Q3 		– Sell
-8,317
Closed -$246K – 207
2020
Q2 		$246K Buy
+8,317
New +$217K 0.04% 170

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

HoyleCohen's EDIT Position: Q2 2024 in Review

HoyleCohen opened a new position in Editas Medicine (EDIT) in Q2 2024: 11,834 shares worth $55.3K. The stake represents ﹤0.01% of the portfolio and ranks #271 among its holdings. This is a return to the name: HoyleCohen previously reported a position in EDIT as recently as Q4 2021.

HoyleCohen first reported a position in EDIT in Q2 2020 and has held it in 7 quarters since. The position peaked at $637K in Q4 2020. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • HoyleCohen held 11,834 shares of Editas Medicine worth $55.3K as of Q2 2024.
  • Editas Medicine was a new HoyleCohen position in Q2 2024.
  • Editas Medicine made up ﹤0.01% of HoyleCohen's portfolio in Q2 2024, its #271 holding.
  • HoyleCohen first reported a position in Editas Medicine in Q2 2020 and has held it in 7 quarters since.
  • HoyleCohen's Editas Medicine position peaked at $637K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.